Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States (Q56355648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

1 reference

1 reference

United States of America

1 reference

Correction to: Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States

inferred from title

corrigendum / erratum

0 references

author name string

Konstantinos C Siontis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Xiaosong Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Ashley Eckard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Nicole Bhave

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Kevin He

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Anca Tilea

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Austin G Stack

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Rajesh Balkrishnan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Xiaoxi Yao

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Peter A Noseworthy

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Nilay D Shah

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Rajiv Saran

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Brahmajee K Nallamothu

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Douglas E Schaubel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

English

0 references

publication date

1 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

1519-1529

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients

3 April 2020

cites work

1 reference

12 December 2020

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

12 December 2020

The increasing prevalence of atrial fibrillation among hemodialysis patients

1 reference

12 December 2020

An automated database case definition for serious bleeding related to oral anticoagulant use.

1 reference

12 December 2020

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

12 December 2020

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

12 December 2020

Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation

1 reference

12 December 2020

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.

1 reference

12 December 2020

Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis

1 reference

12 December 2020

Edoxaban versus warfarin in patients with atrial fibrillation

1 reference

12 December 2020

Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis

1 reference

12 December 2020

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society

1 reference

12 December 2020

Comparable ascertainment of newly-diagnosed atrial fibrillation using active cohort follow-up versus surveillance of centers for medicare and medicaid services in the atherosclerosis risk in communities study.

1 reference

12 December 2020

Matching methods for obtaining survival functions to estimate the effect of a time-dependent treatment

1 reference

12 December 2020

Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study

1 reference

12 December 2020

Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis

1 reference

12 December 2020

On the use and misuse of scalar scores of confounders in design and analysis of observational studies

1 reference

12 December 2020

National Trends in Ambulatory Oral Anticoagulant Use.

1 reference

12 December 2020

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis.

1 reference

12 December 2020

Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis

1 reference

12 December 2020

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

1 reference

12 December 2020

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

1 reference

12 December 2020

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

1 reference

12 December 2020

Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis

1 reference

12 December 2020

Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study.

1 reference

12 December 2020

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

1 reference

12 December 2020

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis

1 reference

12 December 2020

Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation

1 reference

12 December 2020

Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction

1 reference

12 December 2020

Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration

1 reference

12 December 2020

Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.

1 reference

12 December 2020

Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

1 reference

12 December 2020

Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation

1 reference

12 December 2020

10.1161/CIRCULATIONAHA.118.035418

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29954737%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference